GLP1R and type 2 diabetes mellitus: Importantly, high- to moderate-quality evidence highlighted the benefits of GLP-1 receptor agonists (GLP-1 RAs) in individuals with type 2 diabetes or overweight, underscoring their role not only in glycemic control but also in weight management and cardiovascular prevention (42).